Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Trading Statement

20 May 2026 07:00

RNS Number : 9774E
Mortgage Advice Bureau (Hldgs) PLC
20 May 2026
Ā 

20 May 2026

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

Ā 

AGM Trading Statement

Ā 

Mortgage Advice Bureau (Holdings) plc (LSE: MAB1),Ā a leading technology-drivenĀ UKĀ property finance service,Ā will hold its Annual General Meeting at 12:30pm today during which Michael Jones, Chair, will make the following statement:

"On 27 April 2026, alongside publication of its prospectus, the Company reported that it had entered 2026 with good momentum, with mortgage applications in the first 16 weeks of 2026 19% higher year-on-year.

This positive momentum has continued, with mortgage applications in the first 19 weeks of 2026 15% higher year-on-year, in line with the Board's expectations. During March and April, a period of heightened macroeconomic and interest rate uncertainty led to four weeks of accelerated refinancing activity, as customers moved to fix rates early ahead of their product expiry dates. Application levels have since normalised, with refinancing activity expected to remain robust through the remainder of 2026.

The Company's customer acquisition and retention strategies are supporting continued growth in lead flow, underpinning MAB's long track record of year-on-year revenue growth across all market conditions."

Ā 

Enquiries:

Investor Relations investor.relations@mab.org.uk

Camarco mab@camarco.co.uk

Ā 

About MAB:

MAB is a leading UK property finance platform that connects customers, advisers, lenders, and insurers throughout the homeownership journey. Through its scalable, technology-driven intermediary model, MAB delivers personalised mortgage and protection advice via its proprietary platform, supported by deep customer insight and a data-rich, digitally enabled framework.

Through its partner firms, known as Appointed Representatives (ARs), MAB has over 2,100 advisers providing expert advice across mortgages, specialist lending, protection and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visitĀ www.mortgageadvicebureau.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
NOAUKANRNBUVAAR
Date   Source Headline
16th Oct 20187:00 amRNSDirector/PDMR Shareholding
4th Oct 20182:24 pmRNSHolding(s) in Company
4th Oct 20188:11 amRNSHolding(s) in Company
28th Sep 20182:16 pmRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSHalf-year Report
14th Sep 20184:43 pmRNSDirector/PDMR Shareholding
14th Sep 20187:00 amRNSChange of Adviser
31st Aug 201811:08 amRNSDirector/PDMR Shareholding
28th Aug 20184:10 pmRNSHolding(s) in Company
14th Aug 20183:13 pmRNSDirector/PDMR Shareholding
2nd Aug 201812:07 pmRNSSecond Price Monitoring Extn
2nd Aug 201812:02 pmRNSPrice Monitoring Extension
31st Jul 20185:05 pmRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSPre-close Trading Update
16th Jul 20182:34 pmRNSDirector/PDMR Shareholding
2nd Jul 20186:43 pmRNSHolding(s) in Company
2nd Jul 20186:43 pmRNSHolding(s) in Company
29th Jun 20185:06 pmRNSDirector/PDMR Shareholding
14th Jun 20185:28 pmRNSDirector/PDMR Shareholding
7th Jun 20187:00 amRNSBoard Appointment
31st May 20186:16 pmRNSDirector/PDMR Shareholding
23rd May 20184:08 pmRNSDirector/PDMR Shareholding
17th May 20183:10 pmRNSResult of AGM
17th May 201810:31 amRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSAGM Statement
15th May 20187:00 amRNSDirector/PDMR Shareholding
30th Apr 20184:34 pmRNSDirector/PDMR Shareholding
17th Apr 20182:08 pmRNSPosting of Report and Accounts & Notice of AGM
16th Apr 20183:49 pmRNSDirector/PDMR Shareholding
10th Apr 20186:20 pmRNSGrant of options and Director dealing
6th Apr 20187:00 amRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSBoard Appointment
29th Mar 20183:23 pmRNSDirector/PDMR Shareholding
28th Mar 20187:26 amRNSBlock Admission Application
20th Mar 20187:00 amRNSFinal Results for the year ended 31 December 2017
15th Mar 20189:38 amRNSDirector/PDMR Shareholding
28th Feb 20184:00 pmRNSDirector/PDMR Shareholding
15th Feb 20188:07 amRNSDirector/PDMR Shareholding
31st Jan 20186:15 pmRNSDirector/PDMR Shareholding
22nd Jan 20187:00 amRNSPre-close Trading Update
15th Jan 20183:31 pmRNSDirector/PDMR Shareholding
8th Jan 20188:56 amRNSNon-Executive Director Board changes
28th Dec 20177:00 amRNSDirector/PDMR Shareholding
14th Dec 20175:59 pmRNSDirector/PDMR Shareholding
30th Nov 20174:23 pmRNSDirector/PDMR Shareholding
14th Nov 20174:31 pmRNSDirector/PDMR Shareholding
13th Nov 201711:21 amRNSHolding(s) in Company
31st Oct 20176:24 pmRNSDirector/PDMR Shareholding
16th Oct 20174:29 pmRNSDirector/PDMR Shareholding
13th Oct 20173:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.